Topical Simvastatin as Host-Directed Therapy against Severity of Cutaneous Leishmaniasis in Mice
We recently demonstrated that statins mediate protection against intracellular pathogens, Mycobacterium tuberculosis and Listeria monocytogenes in mice. Here, we investigated the immunomodulatory potential of simvastatin as a topical or systemic host-directed drug therapy in controlling inflammatory...
Main Authors: | Parihar, Suraj P., Hartley, Mary-Anne, Hurdayal, Ramona, Guler, Reto, Brombacher, Frank |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025842/ |
Similar Items
-
Simvastatin Enhances Protection against Listeria monocytogenes Infection in Mice by Counteracting Listeria-Induced Phagosomal Escape
by: Parihar, Suraj P., et al.
Published: (2013) -
Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape.
by: Suraj P Parihar, et al. -
Efficacy of adding topical simvastatin to topical calcipotriol on improvement of cutaneous plaque psoriasis
by: Iraji, Fariba, et al.
Published: (2014) -
Deletion of IL-4 Receptor Alpha on Dendritic Cells Renders BALB/c Mice Hypersusceptible to Leishmania major Infection
by: Hurdayal, Ramona, et al.
Published: (2013) -
Imaging of the host/parasite interplay in cutaneous leishmaniasis
by: Millington, Owain R., et al.
Published: (2010)